Clinical Trial Update: Efficacy and Safety of Namilumab (MT203) for Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 study of namilumab (MT203) for plaque psoriasis completed with posted efficacy and safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Namilumab (namilumab)

Snippet

Sponsor: Takeda | Conditions: Plaque Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2017-04-07